Universal Corporation

UVV Consumer Defensive Tobacco

Universal Corporation’s revenue for fiscal 2026 (year ended March 2026) was $2.9 billion, down 0.77% from fiscal 2025. In the quarter to June 2026, revenue fell 11.8%, EPS fell 158.8%, free cash flow grew 38.8% and total debt was flat, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.

40.55 0.12 +0.30%
Market cap
$1.0B
P/E
53.4×
Fwd P/E
12.5×
Dividend yield
8.14%
F-score
5/9
Altman Z
3.05
Beneish M
−2.67
Dividend safety
32/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Revenue
2,924.47 2,947.28 2,748.57 2,569.82 2,103.60 1,983.36 1,909.98 2,227.15 2,033.95 2,071.22
Revenue Growth
(0.77%) 7.23% 6.96% 22.16% 6.06% 3.84% (14.24%) 9.50% (1.80%) (2.32%)
Cost of Revenue
2,412.45 2,398.63 2,212.48 2,111.54 1,694.68 1,597.35 1,553.17 1,820.56 1,662.00 1,676.54
Gross Profit
512.02 548.66 536.10 458.28 408.93 386.00 356.81 406.59 371.95 394.68
SG&A Expenses
300.67 305.29 310.57 277.21 240.69 219.79 222.90 225.12 201.12 211.92
Operating Income
168.45 232.80 222.01 181.07 160.31 147.81 126.37 161.17 170.83 178.40
Non-operating Income/Expense
(65.80) (78.58) (57.93) (39.10) (18.05) (22.08) (13.08) (9.85) (4.15) (9.16)
Non-operating Interest Expenses
74.04 79.64 66.27 49.30 27.75 24.95 19.85 17.51 15.62 16.28
EBT
102.65 154.22 164.08 141.97 142.27 125.73 113.29 151.32 166.68 169.24
Income Tax Provision
46.66 40.95 31.11 11.73 38.66 29.41 35.29 41.19 50.51 56.73
Income after Tax
56.00 113.27 132.97 130.24 103.60 96.31 78.00 110.13 116.17 112.51
Dividends (Preferred)
— — 0.00 0.00 0.00 — — — — 85.41
Non-Controlling Interest
23.36 18.22 13.37 6.18 17.03 8.90 6.32 6.01 10.51 6.20
Net Income Common
32.64 95.05 119.60 124.05 86.58 87.41 71.68 104.12 105.66 20.89
EPS (Basic)
1.30 3.81 4.81 5.01 3.50 3.55 2.87 4.14 4.18 0.89
EPS (Diluted)
1.30 3.78 4.78 4.97 3.47 3.53 2.86 4.11 4.14 0.88
Shares (Basic, Weighted)
25.04 24.95 24.85 24.77 24.76 24.66 24.98 25.13 25.28 23.43
Shares (Diluted, Weighted)
25.17 25.13 25.04 24.94 24.92 24.79 25.11 25.33 25.51 23.77
Gross Margin
17.51% 18.62% 19.50% 17.83% 19.44% 19.46% 18.68% 18.26% 18.29% 19.06%
EBIT Margin
5.76% 7.90% 8.08% 7.05% 7.62% 7.45% 6.62% 7.24% 8.40% 8.61%
EBT margin
3.51% 5.23% 5.97% 5.52% 6.76% 6.34% 5.93% 6.79% 8.19% 8.17%
Net Profit Margin
1.12% 3.22% 4.35% 4.83% 4.12% 4.41% 3.75% 4.68% 5.19% 1.01%
Free Cash Flow Margin
2.95% 9.10% (5.03%) (2.50%) 0.22% 8.35% (1.27%) 5.65% 2.58% 10.47%
EBITDA
262.95 292.57 280.34 238.37 212.84 192.54 164.75 198.27 205.66 214.31
EBIT
168.45 232.80 222.01 181.07 160.31 147.81 126.37 161.17 170.83 178.40
Income from Continuous Operations
56.00 113.27 132.97 130.24 103.60 96.31 78.00 110.13 116.17 112.51
Consolidated Net Income/Loss
56.00 113.27 132.97 130.24 103.60 96.31 78.00 110.13 116.17 112.51
EPS (Basic, from Continuous Ops)
2.24 4.54 5.35 5.26 4.18 3.91 3.12 4.38 4.60 4.80
EPS (Basic, Consolidated)
2.24 4.54 5.35 5.26 4.18 3.91 3.12 4.38 4.60 4.80
EPS (Diluted, from Cont. Ops)
2.22 4.51 5.31 5.22 4.16 3.89 3.11 4.35 4.55 4.73
Shares (Diluted, Average)
25.17 25.13 25.04 24.94 24.92 24.79 25.11 25.33 25.28 23.77
EPS (Diluted, Consolidated)
2.22 4.51 5.31 5.22 4.16 3.89 3.11 4.35 4.55 4.73
EBITDA Margin
8.99% 9.93% 10.20% 9.28% 10.12% 9.71% 8.63% 8.90% 10.11% 10.35%
Operating Cash Flow Margin
4.41% 11.09% (2.72%) (0.41%) 2.13% 11.11% 0.57% 7.39% 3.99% 12.09%

Fold the line items

In millions of $ except per-share values · columns are period end dates